In addition to IL-17, activated T17 and T17/1 cells produce IL-22, IL-26, and IL-29, which all have relevance to psoriatic lesions (figure 2B).44,46,81,82 IL-22 acts via IL-22R1, a transmembrane receptor that is expressed only by specific tissue cells, including keratinocytes but not immune cells